Effect of synbiotic supplementation in children and adolescents with cystic fibrosis: A randomized controlled clinical trial

European Journal of Clinical Nutrition

Volumn 72, Issue 5, 2018, Pages 736-743

  De Freitas, Maiara Brusco ^a   Moreira, Emilia Addison Machado ^a   Oliveira, Diane De Lima ^a   Tomio, Camila ^a   Da Rosa, Julia Salvan ^a   Moreno, Yara Maria Franco ^a   Barbosa, Eliana ^b   Ludwig Neto, Norberto ^b   Buccigrossi, Vittoria ^c   Guarino, Alfredo ^c   Fröde, Tânia Silvia ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b HOSPITAL INFANTIL JOANA DE GUSMÃO   (Brazil)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTOFOS; MYELOPEROXIDASE; NITRIC OXIDE; PLACEBO; SYNBIOTIC AGENT; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADOLESCENT; AGE; ANTIINFLAMMATORY ACTIVITY; ARM CIRCUMFERENCE; BIFIDOBACTERIUM ANIMALIS; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; BURKHOLDERIA CEPACIA; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FORCED EXPIRATORY VOLUME; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; LUNG FUNCTION; MALE; MICROBIOLOGICAL EXAMINATION; NUTRITIONAL STATUS; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; NUTRITIONAL ASSESSMENT; PRESCHOOL CHILD;

ADOLESCENT; BIFIDOBACTERIUM ANIMALIS; BIOMARKERS; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERLEUKIN-6; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; MALE; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; SYNBIOTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85038930743     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/s41430-017-0043-4     Document Type: Conference Paper

References (35)

1. Kieninger E, Regamey N. Targeting inflammation in cystic fibrosis. Respiration 2010;79:189-90.
2. Courtney JM, Ennis M, Elborn JS. Cytokines and inflammatory mediators in cystic fibrosis. J Cyst Fibros. 2004;3:8.
3. Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006;8:1327-36.
4. Lomax AR, Calder PC. Prebiotics, immune function, infection and inflammation: A review of the evidence. Br J Nutr 2009;101:633-58.
5. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2009;29:508-18.
6. Lu R, Fasano S, Madayiputhiya N, Morin NP, Nataro J, Fasano A, Isolation, identification, and characterization of small bioactive peptides from Lactobacillus GG conditional media that exert both anti-Gram-negative and Gram-positive bactericidal activity. J Pediatr Gastroenterol Nutr. 2009;49:23-30
7. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007;132:562-75.
8. Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh SK, Valence F, et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci Usa 2008;105:19474-9.
9. Hoarau C, Martin L, Faugaret D, Baron C, Dauba A, Aubert-Jacquin C, et al. Supernatant from bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells. PLoS One. 2008;3:e2753
10. Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, Maiuri L, et al. Effect of lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: A pilot study. Clin Nutr 2007;26:322-8.
11. Weiss B, Bujanover Y, Yahav Y, Vilozni D, Fireman E, Efrati O. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr Pulmonol 2010;45:536-40.
12. Pereira LC, Moreira EA, Bennemann GD, Moreno YM, Buss Zda S, Barbosa E, et al. Influence of inflammatory response, infection, and pulmonary function in cystic fibrosis. Life Sci 2014;109:30-36.
13. Pinto ICdS, Silva CPd, Britto MCAd. Perfil nutricional, clínico e socioeconômico de pacientes com fibrose cística atendidos em um centro de referência no nordeste do Brasil. J Bras De Pneumol 2009;35:137-43.
14. Voci SM. Estudo de calibração do questionário de frequência alimentar para adolescentes - QFAA a ser utilizado em um estudo de coorte de escolares de Piracicaba, SP. Mestre thesis, Universidade de São Paulo, 2006.
15. United States Department of Agriculture, Agriculture Research Service USDA National nutrientdatabase for standard reference, release 28. [cited 2016. September 18]. Available from: https://ndb.nal.usda.gov/ndb/foods/show/2371?fgcd=&manu=&lfacet=&format=&count=&max=35&offset=&sort=&qlookup=raisins. Available from: https://ndb.nal.usda.gov/ndb/search/list.
16. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002;35:246-59.
17. Lahiri T, Hempstead SE, Brady C, Cannon CL, Clark K, Condren ME, et al. Clinical practice guidelines from the cystic fibrosis foundation for preschoolers with cystic fibrosis. Pediatrics. 2016;137:e20151784
18. WHO. Physical status: The use and interpretation of anthropometry. In: ORGANIZATION WH, editor. Geneva: 1995. p 460.
19. Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981;34:2540-5.
20. Rao TS, Currie JL, Shaffer AF, Isakson PC. Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation 1993;17:723-41.
21. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-8.
22. Wallach J. Wallach interpretação de exames laboratoriais. Rio de Janeiro, RJ: Guanabara Koogan; 2013.
23. Cohen J. A power primer. Psychol Bull 1992;112:155-9.
24. Dodge JA, Turck D. Cystic fibrosis: nutritional consequences and management. Best Pract Res Clin Gastroenterol 2006;20:531-46.
25. Shepherd RW, Greer RM, McNaughton SA, Wotton M, Cleghorn GJ. Energy expenditure and the body cell mass in cystic fibrosis. Nutrition 2001;17:22-25.
26. Panagopoulou P, Fotoulaki M, Nikolaou A, Nousia-Arvanitakis S. Prevalence of malnutrition and obesity among cystic fibrosis patients. Pediatr Int 2014;56:89-94.
27. Annual Data Report Cystic Fibrosis Foundation 2014 [cited] 90]. Available from: https://www.cff.org/2014-Annual-Data-Report.pdf
28. Turck D, Braegger CP, Colombo C, Declercq D, Morton A, Pancheva R, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr 2016;35:557-77.
29. Di Nardo G, Oliva S, Menichella A, Pistelli R, Biase RVD, Patriarchi F, et al. Lactobacillus reuteri ATCC55730 in cystic fibrosis. J Pediatr Gastroenterol Nutr 2014;58:81-6.
30. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001;5:62-71.
31. Calvert JW. Cardioprotective effects of nitrite during exercise. Cardiovasc Res 2011;89:499-506.
32. Jean-Baptiste E. Cellular mechanisms in sepsis. J Intensive Care Med 2007;22:63-72.
33. del Campo R, Garriga M, Perez-Aragon A, Guallarte P, Lamas A, Maiz L, et al. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study. J Cyst Fibros. 2014;13:716-22.
34. Stecenko AA, King G, Torii K, Breyer RM, Dworski R, Blackwell TS, et al. Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells. Inflammation 2001;25:145-55.
35. Chmiel JF, Konstan MW, Saadane A, Krenicky JE, Lester Kirchner H, Berger M. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. Am J Respir Crit Care Med 2002;165:1176-81.